Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayur Narkhede

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Immune Dysfunction and Consequences in Chronic Lymphocytic LeukemiaMayur Narkhede, Chaitra S Ujjani
Future Oncology (London, England)|July 14, 2020
Copanlisib in the treatment of non-Hodgkin lymphomaMayur Narkhede, Bruce D Cheson
Oncotargets and Therapy|July 11, 2018
Primary effusion lymphoma: current perspectivesMayur Narkhede, Shagun Arora, Chaitra Ujjani
Expert Review of Hematology|August 25, 2018
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphomaMayur Narkhede, Maryam Sarraf Yazdy, Bruce Cheson
Hematology/Oncology Clinics of North America|June 24, 2019
Targeting Biology in Non-Hodgkin LymphomaMayur Narkhede, Maryam Sarraf Yazdy, Bruce D Cheson
Annals of Translational Medicine|July 19, 2021
CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challengesMayur Narkhede, Amitkumar Mehta, Stephen M Ansell, et al.
Blood Advances|May 13, 2022
Evaluating real-world treatment patterns and outcomes of mantle cell lymphomaMayur Narkhede, Gaurav Goyal, Lauren Shea, et al.
Haematologica|December 1, 2022
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United StatesGaurav Goyal, Tylan Magnusson, Xiaoliang Wang, et al.
Ejhaem|March 5, 2025
Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United StatesLauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2023
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United StatesAllison Winter, Nicholas Liu, Andy Surinach, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Immune Dysfunction and Consequences in Chronic Lymphocytic LeukemiaMayur Narkhede, Chaitra S Ujjani
Future Oncology (London, England)|July 14, 2020
Copanlisib in the treatment of non-Hodgkin lymphomaMayur Narkhede, Bruce D Cheson
Oncotargets and Therapy|July 11, 2018
Primary effusion lymphoma: current perspectivesMayur Narkhede, Shagun Arora, Chaitra Ujjani
Expert Review of Hematology|August 25, 2018
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphomaMayur Narkhede, Maryam Sarraf Yazdy, Bruce Cheson
Hematology/Oncology Clinics of North America|June 24, 2019
Targeting Biology in Non-Hodgkin LymphomaMayur Narkhede, Maryam Sarraf Yazdy, Bruce D Cheson
Annals of Translational Medicine|July 19, 2021
CAR T-cell therapy in mature lymphoid malignancies: clinical opportunities and challengesMayur Narkhede, Amitkumar Mehta, Stephen M Ansell, et al.
Blood Advances|May 13, 2022
Evaluating real-world treatment patterns and outcomes of mantle cell lymphomaMayur Narkhede, Gaurav Goyal, Lauren Shea, et al.
Haematologica|December 1, 2022
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United StatesGaurav Goyal, Tylan Magnusson, Xiaoliang Wang, et al.
Ejhaem|March 5, 2025
Overall and Cause-Specific Mortality Among Patients With Cutaneous T-Cell Lymphoma in the United StatesLauren Shea, Mayur Narkhede, Karthik Chamarti, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2023
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United StatesAllison Winter, Nicholas Liu, Andy Surinach, et al.
Pageof 3